Pityriasis Rosea Like Drug Rash – A Need to Identify the Disease in Childhood
Published: August 1, 2014 | DOI: https://doi.org/10.7860/JCDR/2014/.4652
Maitreyee Panda, Nibedita Patro, Monalisa Jena, Mrutunjay Dash, Swati Mishra
1. Assistant Professor, Department of Skin & VD, IMS & SUM Hospital, S’O’A University, Bhubaneswar, Odisha, India.
2. Assistant Professor, Department of Skin & VD, IMS & SUM Hospital, S’O’A University, Bhubaneswar, Odisha, India.
3. Assistant Professor, Department of Pharmacology, IMS & SUM Hospital, S’O’A University, Bhubaneswar, Odisha, India.
4. Associate Professor, Department of Paediatrics, IMS & SUM Hospital, S’O’A University, Bhubaneswar, Odisha, India.
5. Associate Professor, Department of Pharmacology, IMS & SUM Hospital, S’O’A University, Bhubaneswar, Odisha, India.
Correspondence
Dr. Maitreyee Panda,
Assistant Professor, Department of Skin & VD, IMS & SUM Hospital, Sector – 8, Kalinga Nagar,
Bhubaneswar – 751003, Odisha, India.
Phone: 9437218952, E-mail: pandamaitreyee@gmail.com
Pityriasis rosea is a common dermatosis named by Gibert in 1860. It is an acute self limiting papulosquamous disease, probably infective in origin affecting healthy adolescents and young adults. It is characterized by distinctive skin eruptions and minimal constitutional symptoms. Drug induced pityriasis rosea tend to occur in older generation and resolution seen only after withdrawal of the offending drug. We report a case of 12-year-old boy with erythematous papules distributed over trunk and proximal arms after nimesulide therapy consistent with a clinical diagnosis of atypical pityriasis rosea. The relation of drug and development of pityriasis rosea is confirmed by dechallenge test of the suspected drug.
[
FULL TEXT ] | [ PDF]